Home
About Us
Team
Programs
Publications
Market Opportunity
Investors/News
Contact
Investor Relations
Our breakthrough treatment solutions have the potential to impact the $3 Billion low testosterone (low T) market.
We are on a mission to transform the way low-T or deficiency is treated.
Press Releases, Articles & News
Acesis Biomed Appoints Dr. Frederic Fasano, Pharm.D, MBA, ICD.D to the Board of Directors as Chairman 09/09/2025
Acesis Biomed Secures Patents Advancing Testosterone-Inducing Drug Development 06/30/2025
Acesis BioMed Launches Crowdfunding Campaign to Develop a Novel Treatment for low Testosterone in Men 03/20/2025
Startups Disrupt Testosterone Therapy Market as Younger Men Fuel Demand 08/26/2025
Business Honor – Smartest Companies to Watch 2025
MenAlive.com - New Health Technology for Men Over 40 07/16/2025
The Good Men Project – New Cutting-Edge Health Technologies for All Men Over 40
